Microparticles: A component of various diseases

Polskie Archiwum Medycyny Wewnetrznej

Volumn 122, Issue SUPPL.1, 2012, Pages 24-29

  Budaj, Miroslav ^a   Poljak, Zuzana ^a   Ďuriš, Ivan ^b   Kaško, Martin ^b   Imrich, Richard ^c   Kopáni, Martin ^b   Maruščáková, Lenka ^a   Hulín, Ivan ^a  

^a Faculty of Natural Sciences   (Slovakia)

^b UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Cardiovascular disease; Cellular biology; Cellular interactions; Microparticles; Microvesicles

Indexed keywords

CELL MARKER; D DIMER; NITRIC OXIDE; VASCULOTROPIN;

ANGIOGENESIS; ANTIGEN PRESENTING CELL; APOPTOSIS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CANCER CELL; CELL COMMUNICATION; CELL FUNCTION; CELL INTERACTION; CELL MOTILITY; CELL PROLIFERATION; CELL VACUOLE; COLORECTAL CARCINOMA; CORONARY ARTERY DISEASE; CYTOLOGY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; EXOSOME; HEART INFARCTION; HODGKIN DISEASE; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; INTRACELLULAR SIGNALING; LIPID VESICLE; MELANOMA; MICROENVIRONMENT; MICROPARTICLE; MONOCYTE; NEOPLASM; NONHUMAN; PARTICLE SIZE; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; THROMBOCYTE; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR DISEASE; VENOUS THROMBOEMBOLISM;

EID: 84872811994     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1489     Document Type: Review

References (51)

1. Chargaff E, West R. The biological significance of the thromboplastic protein of blood. J Biol Chem. 1946; 166: 189-197.
2. Wolf P The nature and significance of platelet products in human plasma. Br J Haematol. 1967; 13: 269-288.
3. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res. 2003; 59: 277-287.
4. Orozco AF, Lewis DE. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A. 2010; 77: 502-514.
5. Smalley DM, Sheman NE, Nelson K, Theodorescu D. Isolation and identification of potential urinary microparticle biomarkers of bladder cancer. J Proteome Res. 2008; 7: 2088-2096.
6. Graves LE, Ariztia EV, Navari JR, et al. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res. 2004; 64: 7045-7049.
7. Boilard E, Nigrovic PA, Larabee K, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science. 2010; 327: 580-583.
8. Anderson HC, Garimella R, Tague SE. The role of matrix vesicles in growth plate development and biomineralization. Front Biosci. 2005; 10: 822-837.
9. Morel O, Toti F, Hugel B, Freyssinet JM. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol. 2004; 11: 156-164.
10. Ratajczak J, Miekus K, Kucia M, et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia. 2006; 20: 847-856.
11. Mytar B, Baj-Krzyworzeka M, Majka M, et al. Human monocytes both enhance and inhibit the growth of human pancreatic cancer in SCID mice. Anticancer Res. 2008; 28: 187-192.
12. Mashburn LM, Whiteley M. Membrane vesicles traffic signals and facilitate group activities in a prokaryote. Nature. 2005; 437: 422-425.
13. Anderson HC. Matrix vesicles and calcification. Curr Rheumatol Rep. 2003; 5: 222-226.
14. Pilzer D, Gasser O, Moskovich O, et al. Emission of membrane vesicles: roles in complement resistance, imunity and cancer. Springer Semin Immunopathol. 2005; 27: 375-387.
15. Johnstone RM. Exosomes biological significance: a concise review. Blood Cells Mol Dis. 2006; 36: 315-321.
16. Muralidharan-Chari V, Clancy J, Plou C, et al. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol. 2009; 19: 1875-1885.
17. Lima LG, Chammas R, Monteiro RQ, et al. Tumor derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine- dependent manner. Cancer Lett. 2009; 283: 168-175.
18. Hugel B, Martinez MC, Kunzelmann C, Freyssinet JM. Membrane microparticles: two sides of the coin. Physiology (Bethesda). 2005; 20: 22-27.
19. Johnstone RM. Exosomes biological significance: a concise review. Blood Cells Mol Dis. 2006; 36: 315-321.
20. Lynch S F, Ludlam CA. Plasma microparticles and vascular disorders. Br J Haematol. 2007; 137: 36-48.
21. Mause S F, von Hundelshausen P, Zernecke A, et al. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol. 2005; 25: 1512-1518.
22. Köppler B, Cohen C, Schlöndorff D, Mack M. Differential mechanisms of microparticle transfer to B cells and monocytes: anti-inflammatory properties of microparticles. Eur J Immunol. 2006; 36: 648-660.
23. Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood. 2005; 106: 1604-1611.
24. Obregon C, Rothen-Rutishauser B, Gitahi SK, et al. Exovesicles from human activated dendritic cells fuse with resting dendritic cells, allowing them to present alloantigens. Am J Pathol. 2006; 169: 2127-2136.
25. Whale TA, Wilson HL, Tikoo SK, et al. Pivotal Advance: passively acquired membrane proteins alter the functional capacity of bovine polymorphonuclear cells. J Leukoc Biol. 2006; 80: 481-491.
26. Smalheiser NR. Do neural cells communicate with endothelial cells via secretory exosomes and microvesicles? Cardiovasc Psychiatry Neurol. 2009; 2009: 383086.
27. Burnier L, Fontana P, Angelillo-Scherrer A, Kwak BR. Intercellular communication in atherosclerosis. Physiology (Bethesda). 2009; 24: 36-44.
28. Horstman LL, Ahn YS. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol. 1999; 30: 111-142.
29. Simons M, Raposo G. Exosomes - vesicular carriers for intercellular communication. Curr Opin Cell Biol. 2009; 21: 575-581.
30. Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009; 9: 581-593.
31. Friend C, Marovitz W, Henie G, et al. Observations on cell lines derived from a patient with Hodgkin's disease. Cancer Res. 1978; 38: 2581-2591.
32. Iero M, Valenti R, Huber V, et al. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ. 2008; 15: 80-88.
33. Skog J, Würdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10: 1470-1476.
34. Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood. 2005; 106: 1604-1611.
35. Mack M, Kleinschmidt A, Brühl H, et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med. 2000; 6: 769-775.
36. Al-Nedawi K, Meehan B, Micallef J, et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol. 2008; 10: 619-624.
37. Sanderson M P, Keller S, Alonso A, et al. Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease- dependent ectodomain shedding and exosome secretion. J Cell Biochem. 2008; 103: 1783-1797.
38. Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005; 438: 932-936.
39. Kim CW, Lee HM, Lee TH, et al. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res. 2002; 62: 6312-6317.
40. Muralidharan-Chari V, Clancy JW, Sedgwick A, D'Souza-Schorey C. Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci. 2010; 123: 1603-1611.
41. Wysoczynski M, Ratajczak MZ. Lung cancer secreted microvesicles: underappreciated modulators of microenvironment in expanding tumors. Int J Cancer. 2009; 125: 1595-1603.
42. Fidler IJ, Poste G. The "seed and soil" hypothesis revisited. Lancet Oncol. 2008; 9: 808.
43. Castellana D, Zobairi F, Martinez MC, et al. Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res. 2009; 69: 785-793.
44. Valenti R, Huber V, Filipazzi P, et al. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res. 2006; 66: 9290-9298.
45. Tesselaar ME, Romijn FP, Van Der Linden IK, et al. Microparticle- associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost. 2007; 5: 520-527.
46. Graves LE, Ariztia EV, Navari JR, et al. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res. 2004; 64: 7045-7049.
47. Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS. Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol. 2004; 286: H1910-H1915.
48. Boulanger CM, Scoazec A, Ebrahimian T, et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation. 2001; 104: 2649-2652.
49. Mallat Z, Benamer H, Hugel B, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation. 2000; 101: 841-843.
50. Chirinos JA, Heresi GA, Velasquez H, et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J. Am Coll Cardiol. 2005; 45: 1467-1471.
51. Lynch SF, Ludlam CA. Plasma microparticles and vascular disorders. Br J Haematol. 2007; 137: 36-48.